Abeona Therapeutics Inc. (ABEO) stock
ABEONasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 8/3027% below fair value
$2.73+0.13 (+5.00%)
Close on Nov 18, 2026Market cap $156.11MP/E –Yield –
Abeona Therapeutics operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Abeona Therapeutics's operating income for the twelve months ending Jun 30, 2026 was -$83.62M. For fiscal 2025 it was -$89.45M. The highest annual figure on record is -$3.13M in fiscal 2014.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$89.45M | – |
| FY2024 | Dec 31, 2024 | -$64.21M | – |
| FY2023 | Dec 31, 2023 | -$47.14M | – |
| FY2022 | Dec 31, 2022 | -$50.92M | – |
| FY2021 | Dec 31, 2021 | -$89.84M | – |
| FY2020 | Dec 31, 2020 | -$81.42M | – |
| FY2019 | Dec 31, 2019 | -$77.09M | – |
| FY2018 | Dec 31, 2018 | -$58.17M | – |
| FY2017 | Dec 31, 2017 | -$27.84M | – |
| FY2016 | Dec 31, 2016 | -$23.88M | – |
| FY2015 | Dec 31, 2015 | -$18.55M | – |
| FY2014 | Dec 31, 2014 | -$3.13M | – |
| FY2013 | Dec 31, 2013 | -$3.80M | – |
| FY2012 | Dec 31, 2012 | -$4.32M | – |
| FY2011 | Dec 31, 2011 | -$7.88M | – |
| FY2010 | Dec 31, 2010 | -$7.76M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$13.65M | – |
| Q1 FY2026 | Mar 31, 2026 | -$23.03M | – |
| Q4 FY2025 | Dec 31, 2025 | -$22.91M | – |
| Q3 FY2025 | Sep 30, 2025 | -$24.02M | – |
| Q2 FY2025 | Jun 30, 2025 | -$22.79M | – |
| Q1 FY2025 | Mar 31, 2025 | -$19.73M | – |
| Q4 FY2024 | Dec 31, 2024 | -$16.67M | – |
| Q3 FY2024 | Sep 30, 2024 | -$15.35M | – |
| Q2 FY2024 | Jun 30, 2024 | -$17.86M | – |
| Q1 FY2024 | Mar 31, 2024 | -$14.33M | – |
| Q4 FY2023 | Dec 31, 2023 | -$13.21M | – |
| Q3 FY2023 | Sep 30, 2023 | -$11.33M | – |
| Q2 FY2023 | Jun 30, 2023 | -$10.55M | – |
| Q1 FY2023 | Mar 31, 2023 | -$12.04M | – |
| Q4 FY2022 | Dec 31, 2022 | -$12.94M | – |
| Q3 FY2022 | Sep 30, 2022 | -$9.38M | – |
| Q2 FY2022 | Jun 30, 2022 | -$8.01M | – |
| Q1 FY2022 | Mar 31, 2022 | -$20.59M | – |
| Q4 FY2021 | Dec 31, 2021 | -$46.65M | – |
| Q3 FY2021 | Sep 30, 2021 | -$14.87M | – |
| Q2 FY2021 | Jun 30, 2021 | -$13.72M | – |
| Q1 FY2021 | Mar 31, 2021 | -$14.60M | – |
| Q4 FY2020 | Dec 31, 2020 | -$14.48M | – |
| Q3 FY2020 | Sep 30, 2020 | -$6.25M | – |
| Q2 FY2020 | Jun 30, 2020 | -$12.48M | – |
| Q1 FY2020 | Mar 31, 2020 | -$48.21M | – |
| Q4 FY2019 | Dec 31, 2019 | -$16.41M | – |
| Q3 FY2019 | Sep 30, 2019 | -$17.65M | – |
| Q2 FY2019 | Jun 30, 2019 | -$23.98M | – |
| Q1 FY2019 | Mar 31, 2019 | -$19.05M | – |
| Q4 FY2018 | Dec 31, 2018 | -$18.01M | – |
| Q3 FY2018 | Sep 30, 2018 | -$16.92M | – |
| Q2 FY2018 | Jun 30, 2018 | -$12.56M | – |
| Q1 FY2018 | Mar 31, 2018 | -$10.68M | – |
| Q4 FY2017 | Dec 31, 2017 | -$8.75M | – |
| Q3 FY2017 | Sep 30, 2017 | -$5.36M | – |
| Q2 FY2017 | Jun 30, 2017 | -$8.44M | – |
| Q1 FY2017 | Mar 31, 2017 | -$5.28M | – |
| Q4 FY2016 | Dec 31, 2016 | -$5.83M | – |
| Q3 FY2016 | Sep 30, 2016 | -$5.17M | – |
See a number that looks wrong?